NAL ER not checked

Trevi Therapeutics

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 3 trial completes
Trials
4 active
10 in total · 3 in the EU

What this is

How it works
How it works isn't classified yet
Tested for
Idiopathic Pulmonary Fibrosis (2 trials), Refractory Chronic Cough
Main trialPhase 3
“The primary purpose is to evaluate the safety and efficacy of NAL ER for the treatment of chronic cough in participants with IPF.”In the company’s words, NCT07868419 on ClinicalTrials.gov
Other names
Nalbuphine · Nalbuphine Extended Release

Other drugs for Idiopathic Pulmonary Fibrosis

All 42 drugs for Idiopathic Pulmonary Fibrosis

Coming up4

Changes1

Last 90 days

Trials10

TrialPhaseCompletesWhat it tests
Phase 3Recruiting Aug 2027 Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine (NAL) Extended-Release (ER) Tablets
Phase 3Recruiting Jun 2028 Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets
Phase 2Recruiting Sep 2027 The Effect of Nalbuphine Extended-Release (NAL ER) on Cough in Participants With Refractory Chronic Cough (RCC)
Phase 1Recruiting 30 Nov 2026 A Study of the Potential Pharmacokinetic Interaction Between Quinidine Sulfate and Nalbuphine Extended-Release Tablets (NAL ER) in Healthy Participants
Phase 2Completed 27 May 2022 A Study of Nalbuphine (Extended Release) ER in Idiopathic Pulmonary Fibrosis (IPF) for Treatment of Cough
Phase 2Completed 6 Jan 2025 Refractory Chronic Cough Improvement Via NAL ER (RIVER)
Phase 2Completed 24 Apr 2025 Cough Reduction in IPF With Nalbuphine ER
Phase 1Completed 12 Sep 2025 A Study of the Pharmacokinetic Interaction Between Pirfenidone, Nintedanib, and Nalbuphine Extended Release (NAL ER) in Healthy Participants
Phase 1Completed 11 May 2026 A Food Effect Study to Evaluate the Relative Bioavailability of Nalbuphine Extended-Release Tablets (NAL ER) in Healthy Participants
Phase 1Completed 30 Jun 2026 NAL ER IPF Respiratory Function and Safety Study
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow NAL ER

Following is part of Solo: you see every change to NAL ER the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in